The Atlanta VA Medical Center is participating in a clinical trial to study the use of semaglutide in treating alcohol use disorder in veterans. This trial is part of a larger study being conducted at 18 VA clinical sites across the US. The study will track over 600 veterans nationwide for 24 weeks to observe the effect of the medication on alcohol cravings and consumption.

Semaglutide is a medication that mimics a naturally occurring hormone and is known to target the brain's reward centers. Further details about the trial are available from Atlanta News First, including information about the potential role of semaglutide in curbing addictive behaviors.